Evaluation of rare and novel splicing variants in the RH system

BACKGROUND: Single nucleotide variants near intron/exon junctions can affect RNA splicing, resulting in weak or loss of blood group antigen expression. We investigated 11 samples with no causative variants found in RH coding exons: three with weak RhD phenotypes and 8 with discordance between phenotypes and DNA prediction for RhCE. METHODS: Serologic and DNA testing was performed by standard methods. RH exons 1-10 and flanking introns were amplified and Sanger sequenced. Variants were evaluated using an in vitro splicing minigene assay. RESULTS: Three weak D phenotypes were associated with intron 1, RHD*149-1G>A, or intron 3, RHD*487-3C>A or RHD*487-3C>G, variants. Splicing assay confirmed activation of a cryptic acceptor site for RHD*149-1A, and both RHD*487-3A and -3G resulted in mis-splicing with minor amounts of normal transcripts. Among eight RHCE discrepancies: three had an intron 4 variant, RHCE*Ce c.635-9G>A, causing a 7-bp insertion, frameshift/stop; five had other intron variants, RHCE*cE c.336-2A>G, RHCE*ce c.486+1G>A, RHCE*ce c.1154-1G>A, RHCE*Ce c.939+1G>A, showing complete splicing disruption, and RHCE*Ce c.148+5G>T with no splicing disruption detectable. CONCLUSIONS: Alleles studied here had intron variants associated with weak or absence of detectable antigen expression. Five are null alleles, RHCE*Ce635-9A, RHCE*ce486+1A, RHCE*ce1154-1A, RHCE*Ce148+5T, and RHCE*Ce939+1A, while RHCE*cE336-2G is associated with E antigen detected by adsorption/elution. Splicing assays support RHD*149-1A may encode an altered RhD, while the low level of normal splicing shown for RHD*487-3A and RHD*487-3G suggests very weak expression but the absence of alloimmunization risk. The minigene splicing assay offers insight into the effect of intron variants on antigen expression.

Authors

Institutions

Publication Details

Journal
Transfusion
Published
2026-11-13
DOI
https://doi.org/10.1111/trf.70480
Primary Topic
Blood groups and transfusion
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of rare and novel splicing variants in the RH system

Connie M. Westhoff, Aline Floch, Isabelle Gourlaouen, Christine Lomas‐Francis et al.
2 links
Transfusion
Blood groups and transfusion
article

Evaluation of rare and novel splicing variants in the RH system

Connie M. Westhoff, Aline Floch, Isabelle Gourlaouen, Christine Lomas‐Francis, June Fuertes, Vege Sunitha, Fichou Yann
article en

Abstract

BACKGROUND: Single nucleotide variants near intron/exon junctions can affect RNA splicing, resulting in weak or loss of blood group antigen expression. We investigated 11 samples with no causative variants found in RH coding exons: three with weak RhD phenotypes and 8 with discordance between phenotypes and DNA prediction for RhCE. METHODS: Serologic and DNA testing was performed by standard methods. RH exons 1-10 and flanking introns were amplified and Sanger sequenced. Variants were evaluated using an in vitro splicing minigene assay. RESULTS: Three weak D phenotypes were associated with intron 1, RHD*149-1G>A, or intron 3, RHD*487-3C>A or RHD*487-3C>G, variants. Splicing assay confirmed activation of a cryptic acceptor site for RHD*149-1A, and both RHD*487-3A and -3G resulted in mis-splicing with minor amounts of normal transcripts. Among eight RHCE discrepancies: three had an intron 4 variant, RHCE*Ce c.635-9G>A, causing a 7-bp insertion, frameshift/stop; five had other intron variants, RHCE*cE c.336-2A>G, RHCE*ce c.486+1G>A, RHCE*ce c.1154-1G>A, RHCE*Ce c.939+1G>A, showing complete splicing disruption, and RHCE*Ce c.148+5G>T with no splicing disruption detectable. CONCLUSIONS: Alleles studied here had intron variants associated with weak or absence of detectable antigen expression. Five are null alleles, RHCE*Ce635-9A, RHCE*ce486+1A, RHCE*ce1154-1A, RHCE*Ce148+5T, and RHCE*Ce939+1A, while RHCE*cE336-2G is associated with E antigen detected by adsorption/elution. Splicing assays support RHD*149-1A may encode an altered RhD, while the low level of normal splicing shown for RHD*487-3A and RHD*487-3G suggests very weak expression but the absence of alloimmunization risk. The minigene splicing assay offers insight into the effect of intron variants on antigen expression.

Transfusion
New York Blood Center (US), Inserm (FR), Établissement Français du Sang (FR), Institut Mondor de Recherche Biomédicale (FR), Génétique, Génomique Fonctionnelle et Biotechnologies (FR)
Good health and well-being
Blood groups and transfusion
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon